المؤلفون: Rastogi P, Buyse ME, Swain SM, Jacobs SA, Robidoux A, Liepman MK, Pajon ER, Dy PA, Posada JG Jr, Melnik MK, Piette F, Geyer CE Jr, Mamounas EP, Wolmark N

المصدر: Clinical Breast Cancer; Aug2011, Vol. 11 Issue 4, p228-234, 7p

المؤلفون: Moore HCF; Cleveland Clinic, Cleveland, Ohio., Barlow WE; SWOG Statistics and Data Management Center, Seattle, Washington., Somlo G; City of Hope Medical Center, Duarte, California., Gralow JR; University of Washington School of Medicine/Seattle Cancer Care Alliance, Seattle, Washington., Schott AF; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan., Hayes DF; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan., Kuhn P; University of Southern California, Los Angeles, California., Hicks JB; University of Southern California, Los Angeles, California., Welter L; University of Southern California, Los Angeles, California., Dy PA; Crossroads Cancer Center (Cancer Care Specialists of Illinois), Heartland NCORP, Decatur, Illinois., Yeon CH; City of Hope, South Pasadena Cancer Center, South Pasadena, California., Conlin AK; Pacific Cancer Research ConsortiumNCORP, Portland, Oregon., Balcueva E; Michigan CRC NCORP, St. Mary's of Michigan, Saginaw, Michigan., Lew DL; SWOG Statistics and Data Management Center, Seattle, Washington., Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, Texas., Pusztai L; Yale University, New Haven, Connecticut., Hortobagyi GN; The University of Texas MD Anderson Cancer Center, Houston, Texas.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Feb 15; Vol. 28 (4), pp. 611-617.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Everolimus*, Anastrozole/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Female ; Fulvestrant ; Humans ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/therapeutic use ; Receptors, Estrogen

المؤلفون: Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. ae378@cinj.rutgers.edu., Hong F; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Habermann TM; Mayo Clinic, Rochester, Minnesota., Advani RH; Stanford Cancer Institute, Stanford, California., Gascoyne RD; British Columbia Cancer Agency, Vancouver, Canada., Witzig TE; Mayo Clinic, Rochester, Minnesota., Quon A; University of California at Los Angeles, California., Ranheim EA; University of Wisconsin, Madison, Wisconsin., Ansell SM; Mayo Clinic, Rochester, Minnesota., Cheema PS; Saint John's Hospital Health East Care System, Maplewood, Minnesota., Dy PA; Decatur Memorial Hospital, Effingham, Illinois., O'Brien TE; Case Western Reserve University, Cleveland, Ohio., Winter JN; Northwestern University, Chicago, Illinois., Cescon TP; Reading Hospital, West Reading, Pennsylvania., Chang JE; University of Wisconsin, Madison, Wisconsin., Kahl BS; Washington University, St. Louis, Missouri.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Sep 01; Vol. 26 (17), pp. 4468-4477. Date of Electronic Publication: 2020 Jun 12.

نوع المنشور: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Lymphoma, Follicular/*drug therapy , Neoplasm Recurrence, Local/*epidemiology, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bendamustine Hydrochloride/administration & dosage ; Bendamustine Hydrochloride/adverse effects ; Bortezomib/administration & dosage ; Bortezomib/adverse effects ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Humans ; Infusions, Intravenous ; Lenalidomide/administration & dosage ; Lenalidomide/adverse effects ; Lymphoma, Follicular/mortality ; Maintenance Chemotherapy/adverse effects ; Maintenance Chemotherapy/methods ; Male ; Middle Aged ; Neoplasm Recurrence, Local/prevention & control ; Progression-Free Survival ; Remission Induction/methods ; Rituximab/administration & dosage ; Rituximab/adverse effects ; Young Adult

المؤلفون: Schott AF; University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA. aschott@umich.edu., Barlow WE; SWOG Statistical Center, Seattle, WA, USA., Van Poznak CH; University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA., Hayes DF; University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA., Moinpour CM; SWOG Statistical Center, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Lew DL; SWOG Statistical Center, Seattle, WA, USA., Dy PA; Heartland Cancer Research NCORP, Crossroads Cancer Center, Effingham, IL, USA., Keller ET; University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA., Keller JM; University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, MI, USA., Hortobagyi GN; University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2016 Aug; Vol. 159 (1), pp. 87-95. Date of Electronic Publication: 2016 Jul 30.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Bone Neoplasms/*drug therapy , Breast Neoplasms/*drug therapy , Dasatinib/*administration & dosage, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Dasatinib/therapeutic use ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Humans ; Middle Aged ; Survival Analysis ; Treatment Outcome